The distinct expression of IFN-γ pathway genes mediated by p63 or Δ133p53 is subtype-dependent, and reduced IFN-γ signaling is associated with poor prognosis across different breast cancer subtypes. The gene discussed is IFNG; the disease is breast carcinoma.